The AtriClip devices are epicardially applied to the base of the left atrial appendage (LAA) during cardiac surgery procedures such that the LAA is permanently excluded from the left atrium of the heart. This exclusion eliminates blood flow and electrical communication of blood between the left atrium (LA) and the LAA and results in the electrical isolation of the LAA from the rest of the heart.1-4
In the latest release of the ACC/AHA/ACCP/HRS Guidelines for diagnosis and management of atrial fibrillation, LAA management was upgraded to the highest recommendation. Over the past two decades, AtriCure has worked tirelessly to develop a portfolio of AtriClip devices that permanently exclude the LAA. Now with a Class IA recommendation, AtriCure is more determined than ever to advocate for the value and importance of LAA exclusion.
The AtriClip devices are available on a variety of delivery systems optimized for open concomitant procedures as well as minimally invasive surgery, both through a thoracotomy and a port.
Computed tomography (CT) before and at 3-year follow-up after AtriClip device implantation. Exemplary CT before AtriClip device placement (A and C) and after implantation depicting the AtriClip device in stable position and fully excluding the left atrial appendage at a 3-year follow up (B and D).8
Development of the AtriClip Device
The safety and effectiveness of this device in atrial rhythm control management, either alone or in combination with ablative treatment, has not been established.
The safety and effectiveness of this device for stroke prevention, either alone or in combination with cardiac surgery, has not been established.
*AtriClip PRO•V Device is not included.